Stanley Druckenmiller
Duquesne Family Office
Profile & Investment Philosophy
Stanley Druckenmiller runs the Duquesne Family Office with the same macro instinct that made his record: concentrate where conviction is highest, and move fast when it changes. In Q2 2026 the book grew to $5.2 billion but spread across 95 positions, with biotech name Natera alone at 17%. He kept building the AI hardware chain - Taiwan Semiconductor (+19%), STMicroelectronics (+19%), Seagate (+141%) - added a fresh Alphabet stake and an eleven-fold Amazon increase, and exited Broadcom, Restaurant Brands and Humana. Roku (-76%) and Teva (-74%) were cut hard.
Track Record
Stanley Druckenmiller compounded roughly 30% annualized at Duquesne Capital between 1981 and 2010 without a single losing year, then converted the shop into the Duquesne Family Office. Across three decades he ran money for himself, Soros' Quantum Fund and outside LPs simultaneously, repeatedly doubling capital in trending macro regimes. Today the Family Office reports roughly $3-4 billion in 13F equity exposure, which is a fraction of total assets. Few public track records pair that length, that consistency and that absence of drawdown years.
Signature Trades
Current Strategy (2026)
Druckenmiller's Q2 2026 13F is a barbell of growth, healthcare and idiosyncratic special situations rather than a clean macro theme. Natera remains his top US equity holding at 17% of a $5.2 billion book that has widened to 95 positions. He kept building the AI hardware chain — Taiwan Semiconductor (+19%), STMicroelectronics (+19%), Seagate (+141%) — multiplied Amazon elevenfold and opened new stakes in Alphabet, Fox and CDW, while adding a large Insmed call position on top of the common. Broadcom, Restaurant Brands, Lattice and Humana were sold, and Roku (-76%), Teva (-74%) and Woodward (-68%) were cut hard. He still expresses macro views through options rather than the old futures-and-FX vehicles, reflecting that he is running family capital, not chasing fund benchmarks.
BMI Counter-Take
Druckenmiller is the cleanest case study against diversification dogma. He runs a handful of high-conviction names, leans on options when conviction is highest and is publicly willing to admit when he is wrong, including the 2024 NVDA exit he himself called a mistake. We respect the process, but copy-trading him is a trap: by the time a 13F lands his thesis can already be reversed. Use his disclosures to learn how a great risk manager sizes ideas, not as a buy list. The real edge is his willingness to do nothing for months and then strike at size, something almost no retail investor actually replicates.
Current Portfolio
LATEST 13F 2026-06-30Latest SEC Form 13F filing. Total portfolio value: $5.21 B. Holdings: 95 positions.
| Security | Type | Shares | Δ vs Prev | Value ($) | Portfolio % |
|---|---|---|---|---|---|
| Natera Inc. | Common | 3.19 M | +4.0% | $865 M | 16.6 % |
| Taiwan Semiconductor Manufac | Common | 589,680 | +19.1% | $282 M | 5.40 % |
| Stmicroelectronics N V | Common | 3.10 M | +18.8% | $232 M | 4.46 % |
| Invesco Exchange Traded Fd T | Call | 821,000 | — | $175 M | 3.35 % |
| Insmed Inc. | Common | 1.42 M | +23.4% | $152 M | 2.92 % |
| Ishares Inc. | Call | 4.23 M | — | $146 M | 2.80 % |
| Insmed Inc. | Call | 1.35 M | ★ NEW | $144 M | 2.76 % |
| Ypf Sociedad Anonima | Common | 3.14 M | -3.0% | $143 M | 2.74 % |
| Amazon Com Inc. | Common | 541,600 | +1082.5% | $129 M | 2.48 % |
| Bbb Foods Inc. | Common | 2.90 M | -6.7% | $121 M | 2.32 % |
SOURCE: SEC Form 13F (2026-08-14). BMI Smart Money Tracker.